Many employer and insurer pathways focus on starting treatment. The real challenge is what happens after the early phase.
Healthcount supports people through the maintenance phase — when motivation fades, routines slip, and the risk of dropout rises.
Employers and insurers investing in GLP-1 pathways commonly see:
Without maintenance support, the investment in starting treatment may not deliver lasting results.
Healthcount is a behavioural maintenance companion that supports people using GLP-1 medicines through the maintenance phase. It provides:
Employers and insurers receive aggregated, anonymised cohort reporting. Individual employee data is never shared.
Individual employee data is never shared. Minimum cohort sizes are enforced to prevent re-identification.
A typical pilot report includes aggregated metrics like these:
Illustrative data only. Actual metrics vary by cohort.
Pilots are designed to be straightforward and low-effort for the employer or insurer.
Define eligibility, agree reporting, set up communications to members
Roll out to pilot participants with onboarding guidance
Regular aggregated read-outs and pilot review
3 to 6 months
50 to 300 employees
Onboarding guidance, aggregated reporting, pilot review
Dashboard and/or monthly PDF suitable for governance packs
Healthcount is designed to require minimal employer effort. Typical setup includes:
You're already paying for the medication. The question is whether it sticks. In a cohort study of 125,474 adults, 64.8% of people without type 2 diabetes discontinued GLP-1 therapy within one year. After stopping, participants regained about two-thirds of the weight they had lost on average.
For employers and insurers, that means repeated funding cycles without stable outcomes. A Healthcount pilot is a bounded, low-risk way to test whether quiet maintenance support reduces stop-start patterns in your funded cohort — with clear metrics and a defined end point.
What proportion of your cohort engages, and for how long. Reported at 8-12 weeks, 3 months, and 6 months.
Drift patterns, medication gap proxies, and safety signposting rates — all aggregated at cohort level, never individual.
At 8-12 weeks and 6 months, a clear report with a scale, adjust, or stop recommendation based on the data.
Data Protection Impact Assessment, privacy and security summary, and clinical boundaries statement — all provided before the pilot starts.
No employer branding, no surveillance feel. It only speaks up when the numbers say it matters. Members use it because it helps, not because they're being watched.
We agree the eligible cohort, reporting cadence, data governance expectations, consent model, and escalation destinations.
You get (in writing):
About 2 hours total from your side.
Members are invited, onboard in minutes, and Healthcount runs quietly. No ongoing HR admin required.
You get:
Cohort scope, governance, consent model, escalation destinations, and success criteria agreed.
Member invitations sent. Onboarding takes a few minutes. No employer account linking required.
First reporting on activation, retention, and early maintenance signals. Enough to assess whether the pilot is on track.
Full evaluation report covering all metrics, with a clear recommendation: scale, adjust, or stop.
All metrics are reported in aggregated, de-identified form. Individual member data is never shared with employers or insurers.
What proportion of enrolled members complete their first check-in within 14 days. Target: 40%.
What proportion of activated members are still active at 8 weeks. “Active” means at least one check-in in the last 14 days. Target: 60%.
Percentage of members with a treatment gap of 28+ days, and restart rate per 100 member-months. Target: lower than baseline by month 6.
Percentage of active members who self-report “on track” at 3 and 6 months. Target: higher than baseline by month 6.
Opt-out rate and reasons, plus median time spent per member per month. Target: under 2 minutes per month for most members.
Pilot pricing is a flat fee — not per member. This keeps things simple and removes friction from the decision.
Pilot programme
Up to 50 members, 6 months
Flat fee
Includes: governance pack, onboarding support, member communications template, all reporting readouts, and evaluation report.
GLP-1 medication typically costs employers around £200 per member per month. Healthcount costs less than 5% of the medication itself.
Pricing depends on cohort size and reporting requirements. Request a pilotand we'll confirm a fixed price.
Employers and insurers never see individual employee health data. All reporting uses aggregated, de-identified metrics with minimum group sizes.
A Data Protection Impact Assessment is provided before the pilot starts, covering all data processing activities.
Healthcount does not prescribe, diagnose, or advise dose changes. Clear signposting to clinical support when needed.
Members can pause or leave at any time. Opt-out rates and reasons are included in reporting for trust monitoring.
Three roles keep scope tight, unblock decisions quickly, and make sure the pilot goes live safely.
A Reward & Benefits or Wellbeing lead who can make decisions and keep scope tight.
An identified group of 30-50 employees on funded GLP-1 treatment. We never see names — just the invitation count and channel.
Confirm data governance expectations are met. We provide the DPIA and privacy summary — your team reviews and signs off.
Employers never see individual data. Members are told this clearly during onboarding. Reporting is always aggregated with minimum group sizes enforced.
The evaluation report includes a clear stop recommendation if results don't justify continuation. You're never locked into a longer commitment.
About 2 hours during setup to align on the operating model. After that, Healthcount runs itself. Reporting is delivered automatically.
You get an evaluation report with aggregated data and a recommendation: scale, adjust, or stop. You decide whether to continue.
Yes. The pilot is designed for a single cohort of 30-50 members. Starting small is the whole point — test with evidence before scaling.
Healthcount does not replace clinical care. All pilot metrics are reported in aggregated, de-identified form. Individual member data is never shared with funders.
Tell us about your GLP-1 pathway and we'll be in touch within 2 business days to confirm whether a pilot makes sense for your organisation.